As Denmark begins talkswith the United States over a potential Greenland deal, the country’s largest industry may not give it much leverage in negotiations, experts told Euronews Health. Denmark’s top ...

On a boat off Kalundborg harbor, Martin Høgh Sørensen steers while his wife, Karin, and friends Michael and Anne-Louise ...

Lotte Bjerre Knudsen grew up on a farm in Denmark, has a very healthy appetite and doesn’t mind a glass of wine at lunch. Though she did balk at dessert.

Men’s Health spoke to Novo Nordisk's Thomas Kruse and Jesper Lau, the two chemists responsible for discovering ...

Novo Nordisk, the maker of in-demand drugs Ozempic and Wegovy, said it will cut thousands of global jobs to simplify operations and reallocate resources toward its diabetes and obesity drugs as rivals ...

Half of people who start taking the GLP-1 weight-loss drug Ozempic drop it within a year, a new study says. About 52% of people in Denmark prescribed semaglutide (Ozempic, Wegovy) for weight loss ...

Novo Nordisk, the Danish drugmaker with a large presence in North Carolina, declined to say how many jobs might be cut in the state. But it indicated a planned Triangle expansion might not be affected ...

A study shows obesity trends have diverged across regions over the past four decades, though it is too early for drugs such ...

Ozempic can help people who are battling alcoholism, a major new clinical trial has concluded. People with alcohol use ...